Lexington, KY (PRWEB) November 29, 2011
MedPro Safety Products, Inc. (OTCBB: MPSP), a leading developer of transformational technologies that enable safer medication delivery and blood collection, today announced the launch of its redesigned corporate website (http://www.medprosafety.com). The updated website includes a more comprehensive listing of the Company’s products, including a section on those used in drug delivery – the Prefilled Passive Safety Syringe, the Prefilled IV Shuttle and the MedPro Passive Safety Hypodermic Syringe – in addition to the focus on the blood collection products for phlebotomy applications.
The new website also includes a section called “145 Rose” named after MedPro Safety’s street address in Lexington, Kentucky, that features its product design capabilities. The Company has a track record for developing innovative products with proprietary passive needlestick safety features. It markets its core engineering design and related services like “Voice of the Customer” to other medical device companies seeking to outsource the design of related medical products.
“The new website provides a much enhanced view of the products and services that MedPro offers today,” said Bethany Denning, Director of Corporate Relations. “We are proud of our proprietary products and design expertise. The updated site showcases our core competencies and is a more compelling representation of MedPro and what we have to offer to medical device customers, healthcare workers, investors and other interested audiences.”
About MedPro Safety Products, Inc.
Headquartered in Lexington, Kentucky, MedPro Safety Products, Inc. is a leading developer of safer medication delivery and blood collection systems. The Company licenses, develops and manufactures transformational technologies marketed through its global medical device partners. MedPro’s products address multiple product categories within the medication delivery (injection and infusion) and blood collection (blood collection sets and blood tube holders) markets. Unlike competitive products currently available on the market, MedPro’s products incorporate safety features that operate without user activation, and therefore require little or no clinician training to use. The total global market opportunity for safer medication delivery and blood collection products is believed to be more than $6 billion. For additional information, please refer to the ‘Investor Relations’ link on the Company’s website (http://www.medprosafety.com).